↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

1,427 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   (-)-trans-delta-9-tetrahydrocannabinol   Dronabinol   D00306   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
13 
 2   (im) avonex®   -   -   -   -   1件:
13 
 3   (r) 3-(5-dimethylcarbamoyl-pent-1-enyl)-n-(2-hydroxy-1- methylethyl) benzamide   Pentaerythritol tetranitrate   D01721   -   -   1件:
13 
 4   0,5 mg fingolimod   Fingolimod   D10001   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 5   0.25mg rpc1063   -   -   -   -   1件:
13 
 6   1 - andrographis paniculata p/st extract   -   -   -   -   1件:
13 
 7   1% steroid cream   -   -   -   -   1件:
13 
 8   1-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1h-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone   -   -   -   -   1件:
13 
 9   1.0mg rpc1063   -   -   -   -   1件:
13 
 10   10 milligram (mg) fampridine-sr (4-aminopyridine, 4-ap)   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 11   10000iu vitamin d   Vitamin D   -   -   -   1件:
13 
 12   11c-acetate   Acetic acid C-11, Acetate   -   -   -   3件:
13,
86,
88 
 13   11c-pib   -   -   -   -   1件:
13 
 14   13-pcv booster   -   -   -   -   1件:
13 
 15   13-valent pneumococcal conjugate vaccine (13-pcv)   -   -   -   -   1件:
13 
 16   15 mg fampridine-sr (4-aminopyridine, 4-ap)   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 17   18f-dpa-714 and 18f-fdg   Fludeoxyglucose F-18   -   -   -   1件:
13 
 18   18f-fdg   Fludeoxyglucose F-18   -   -   -   7件:
6,
13,
46,
53,
84,
127,
300 
 19   19 nor vitamin d   Vitamin D   -   -   -   1件:
13 
 20   2 - excipients   -   -   -   -   1件:
13 
 21   2-cda   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 22   2-cda, 2-chloro-2’-deoxy-beta-d-adenosine   Cladribine, Adenosine   D00045, D01370   5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1   17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
13 
 23   2-cda, 2-chloro-2’-deoxy-ß-d-adenosine   Cladribine, Adenosine   D00045, D01370   5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1   17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
13 
 24   2-chloro-2'-deoxyadenosine, 2cda   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 25   2-chloro-2’-deoxyadenosine (2-cda)   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 26   20 mg fampridine-sr (4-aminopyridine, 4-ap)   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 27   20 mg ga   -   -   -   -   1件:
13 
 28   200106 or emd 28162   -   -   -   -   1件:
13 
 29   20mg/0.5ml ga   -   -   -   -   1件:
13 
 30   20mg/0.5ml glatiramer acetate   Acetate, Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 31   23-ppv   -   -   -   -   1件:
13 
 32   23-valent pneumococcal polysaccharide vaccine   -   -   -   -   3件:
13,
46,
53 
 33   23-valent pneumococcal polysaccharide vaccine (23-ppv)   -   -   -   -   1件:
13 
 34   25oh-vitamin d   Vitamin D   -   -   -   1件:
13 
 35   2b3-201   -   -   -   -   1件:
13 
 36   2cda   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 37   3 mg melatonin   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   1件:
13 
 38   3,4-diaminopyridine   -   -   -   -   3件:
11,
12,
13 
 39   4-aminopyridine   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   2件:
3,
13 
 40   4-ap   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 41   4.5 mg naltrexone   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
13 
 42   40 mg ga   -   -   -   -   2件:
2,
13 
 43   40 mg glatiramer acetate   Acetate, Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   2件:
2,
13 
 44   5 mg melatonin   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   1件:
13 
 45   5000iu vitamin d   Vitamin D   -   -   -   1件:
13 
 46   52069.00.01   -   -   -   -   1件:
13 
 47   9060x   -   -   -   -   2件:
13,
149 
 48   95% pure ecgc capsules 200mg   -   -   -   -   1件:
13 
 49   [11c]flumazenil   Flumazenil   D00697   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
13 
 50   [123i]clinde   -   -   -   -   2件:
6,
13 
 51   [14c]-rpc1063 solution (0.1 mg/ml) for oral administration   -   -   -   -   3件:
13,
96,
97 
 52   [18f] pbr06   -   -   -   -   2件:
6,
13 
 53   [18f]-feppa   -   -   -   -   2件:
6,
13 
 54   [18f]dpa-714   -   -   -   -   1件:
13 
 55   [18f]florbetapir and pet imaging   -   -   -   -   1件:
13 
 56   [c-11]methylreboxetine   -   -   -   -   1件:
13 
 57   [f-18]pbr06   -   -   -   -   1件:
13 
 58   [zr-89]oxine-labeled leukocytes pet/mr   Oxyquinoline   D05321   -   -   1件:
13 
 59   A4i antagonist   -   -   -   -   1件:
13 
 60   Ab1010   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   6件:
2,
5,
6,
13,
46,
96 
 61   Abatacept   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 62   Abobotulinumtoxin a   -   -   -   -   1件:
13 
 63   Abr-215062 sodium salt   -   -   -   -   2件:
13,
96 
 64   Abt-555   -   -   -   -   1件:
13 
 65   Abt-874/human monoclonal antibody against il-12   -   -   -   -   1件:
13 
 66   Abx-1431 hcl   -   -   -   -   1件:
13 
 67   Acetaminophen   Acetaminophen   D00217   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   11件:
13,
34,
35,
46,
49,
51,
70,
86,
231,
256,
271 
 68   Acetaminophen tab 650mg   Acetaminophen   D00217   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
13 
 69   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 70   Acetazolamide   Acetazolamide   D00218, D01196   13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9   7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation   6件:
13,
90,
115,
155,
225,
230 
 71   Acetylcysteine   Acetylcysteine   D00221   -   -   14件:
6,
13,
19,
20,
49,
51,
58,
85,
94,
111,
164,
233,
298,
299 
 72   Acetylsalicylic acid   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   3件:
13,
46,
51 
 73   Acetylsalicylic acid at 1st visit,   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
13 
 74   Aclasta   Zoledronic acid   D01968, D06378, D06379, D08689   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   3件:
13,
271,
274 
 75   Aclasta 5 mg infusionslösung   Zoledronic acid   D01968, D06378, D06379, D08689   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 76   Aclasta 5mg solution for infusion   Zoledronic acid   D01968, D06378, D06379, D08689   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
13 
 77   Act-128800   Ponesimod   D11215   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 78   Act-128800 dose 1   Ponesimod   D11215   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 79   Act-128800 dose 2   Ponesimod   D11215   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 80   Act-128800 dose 3   Ponesimod   D11215   1件: S1PR1   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
13 
 81   Acth   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   5件:
13,
66,
145,
193,
222 
 82   Acthar   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   6件:
2,
13,
46,
49,
50,
222 
 83   Acthar gel   -   -   -   -   4件:
13,
46,
49,
84 
 84   Acthar gel (acth)   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
13 
 85   Active comparator receiving extavia®   -   -   -   -   1件:
13 
 86   Active control   -   -   -   -   1件:
13 
 87   Actos (pioglitazone)   Pioglitazone   D00945, D08378   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   1件:
13 
 88   Acyclovir   Acyclovir   D00222   -   -   2件:
13,
28 
 89   Adderall xr   -   -   -   -   1件:
13 
 90   Adderall xr 10 mg   -   -   -   -   1件:
13 
 91   Adderall xr 5mg   -   -   -   -   1件:
13 
 92   Adenosine   Adenosine   D00045   4件: ADORA1, ADORA2A, ADORA2B, ADORA3   12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   3件:
13,
58,
65 
 93   Adrenocorticotropic hormone   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
13,
50,
84 
 94   Adrenocorticotropic hormone (acth) gel (h.p. acthar®)   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
13 
 95   Ads-5102   -   -   -   -   2件:
6,
13 
 96   Ads-5102, 137 mg   -   -   -   -   1件:
13 
 97   Ads-5102, 274 mg   -   -   -   -   1件:
13 
 98   Aert, (r)-baclofen   Baclofen   D00241   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 99   Agee cream   -   -   -   -   1件:
13 
 100   Aimspro   -   -   -   -   2件:
13,
51 
 101   Ain457   -   -   -   -   7件:
13,
37,
41,
46,
56,
96,
271 
 102   Alanine   L-Alanine   D00012   -   -   3件:
13,
298,
299 
 103   Albumin (human) 25%, united states pharmacopeia (usp)   -   -   -   -   2件:
13,
14 
 104   Albuterol   Salbutamol   D02147   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   8件:
12,
13,
86,
89,
113,
231,
256,
299 
 105   Alcohol   Isopropyl alcohol   D00137   -   -   4件:
13,
58,
279,
298 
 106   Alemtuzumab   Alemtuzumab   D02802   -   -   13件:
13,
15,
19,
20,
46,
51,
60,
63,
65,
85,
96,
164,
284 
 107   Alemtuzumab (gz402673)   Alemtuzumab   D02802   -   -   1件:
13 
 108   Alemtuzumab 12 mg   Alemtuzumab   D02802   -   -   1件:
13 
 109   Alemtuzumab 24 mg   Alemtuzumab   D02802   -   -   1件:
13 
 110   Alemtuzumab gz402673   Alemtuzumab   D02802   -   -   1件:
13 
 111   Alemtuzumab immunotherapy   Alemtuzumab   D02802   -   -   1件:
13 
 112   Alemtuzumab injection [lemtrada]   Alemtuzumab   D02802   -   -   1件:
13 
 113   Alfuzosin   Alfuzosin   D01692, D07124   1件: ADRA1A   7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
13 
 114   Alks 8700   -   -   -   -   1件:
13 
 115   Alks 8700 delayed release (dr)   -   -   -   -   1件:
13 
 116   Alks 8700 delayed release (dr) capsule   -   -   -   -   1件:
13 
 117   Allogeneic human umbilical cord tissue-derived mesenchymal stem cells   -   -   -   -   1件:
13 
 118   Alpha lipoic acid   Lipoic Acid   D00048, D00086   -   -   1件:
13 
 119   Alpha-lipoic acid   Lipoic Acid   D00048, D00086   -   -   2件:
2,
13 
 120   Alpha1-antitrypsin   -   -   -   -   1件:
13 
 121   Altri farmaci del sistema nervoso   -   -   -   -   1件:
13 
 122   Amantadine   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   4件:
6,
8,
13,
127 
 123   American ginseng   Panax quinquefolius whole, Nicotinamide   D00036   -   -   1件:
13 
 124   American ginseng extract ht-1001   Panax quinquefolius whole, Nicotinamide, Ginseng   D00036   -   -   1件:
13 
 125   Amiloride   Amiloride   D00649, D07447   3件: SCNN1A, SCNN1B, SCNN1G   2件: Aldosterone-regulated sodium reabsorption, Taste transduction   3件:
13,
225,
299 
 126   Amiloride hydrochloride   Amiloride   D00649, D07447   3件: SCNN1A, SCNN1B, SCNN1G   2件: Aldosterone-regulated sodium reabsorption, Taste transduction   1件:
13 
 127   Amiloride hydrochloride, 2 h2o   Amiloride   D00649, D07447   3件: SCNN1A, SCNN1B, SCNN1G   2件: Aldosterone-regulated sodium reabsorption, Taste transduction   1件:
13 
 128   Amilostad hct   -   -   -   -   1件:
13 
 129   Amilostad hct tablets   -   -   -   -   1件:
13 
 130   Ampyra   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 131   An100226   -   -   -   -   2件:
13,
96 
 132   An100226, bg00002   -   -   -   -   1件:
13 
 133   Anakinra   Anakinra   D02934   2件: IL1R1, IL1R2   15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer   15件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
84,
86,
106,
107,
299 
 134   Androgel 1 % topical gel   -   -   -   -   1件:
13 
 135   Androgel 100mg gel   -   -   -   -   1件:
13 
 136   Andrographolides   -   -   -   -   1件:
13 
 137   Anesthetic topical adhesive synera   -   -   -   -   1件:
13 
 138   Anti lp40 antibody, subclass igg4 la294   -   -   -   -   2件:
13,
46 
 139   Anti-cd25 humanized monoclonal antibody   -   -   -   -   1件:
13 
 140   Anti-cd52 monoclonal antibody   -   -   -   -   1件:
13 
 141   Anti-il-12   -   -   -   -   2件:
13,
96 
 142   Anti-thymocyte globulin   -   -   -   -   18件:
11,
13,
14,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
164,
283,
284,
285 
 143   Anticholinergic medication   -   -   -   -   1件:
13 
 144   Antihistamine   -   -   -   -   2件:
13,
46 
 145   Antimycotic   -   -   -   -   1件:
13 
 146   Antithymocyte   -   -   -   -   1件:
13 
 147   Antithymocyte immunoglobulin (rabbit)   Rabbit   -   -   -   2件:
13,
65 
 148   Arbaclofen   Arbaclofen   D09791   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   2件:
13,
206 
 149   Arbaclofen er tablets   Arbaclofen   D09791   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 150   Arbaclofen extended release tablets   Arbaclofen   D09791   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 151   Arbaclofen placarbil   Arbaclofen, Arbaclofen Placarbil   D08861, D09791   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 152   Arbaclofen placarbil 15 mg bid   Arbaclofen, Arbaclofen Placarbil   D08861, D09791   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 153   Arbaclofen placarbil 30 mg bid   Arbaclofen, Arbaclofen Placarbil   D08861, D09791   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 154   Arbaclofen placarbil 45 mg bid   Arbaclofen, Arbaclofen Placarbil   D08861, D09791   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 155   Aricept   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   4件:
6,
13,
78,
124 
 156   Aricept 10 mg   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
13 
 157   Aricept 10 mg filmdragerade tabletter   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
13 
 158   Aricept 5 mg   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
13 
 159   Aricept 5 mg filmdragerade tabletter   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
13 
 160   Arm 1 - geh120714 (18f) injection   -   -   -   -   1件:
13 
 161   Armodafinil   Armodafinil   D03215   1件: SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   3件:
6,
13,
84 
 162   Arn-6039   -   -   -   -   1件:
13 
 163   Arzerra   Ofatumumab   D09314   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
13 
 164   Asb-683699   -   -   -   -   1件:
13 
 165   Aspartate   aspartate   D00013   -   -   3件:
13,
75,
299 
 166   Aspirin   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   10件:
13,
22,
34,
46,
49,
51,
86,
113,
158,
231 
 167   Aspirin 650mg oral capsule   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
13 
 168   Ata188   -   -   -   -   1件:
13 
 169   Atacicept   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
13,
46,
49,
66 
 170   Atacicept 150 mg   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   3件:
13,
49,
66 
 171   Atacicept 25 mg   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   2件:
13,
66 
 172   Atacicept 75 mg   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   3件:
13,
49,
66 
 173   Atl1102   ATL1102   -   -   -   1件:
13 
 174   Atomoxetine   Atomoxetine   D02574, D07473   1件: SLC6A2   1件: Synaptic vesicle cycle   3件:
6,
8,
13 
 175   Atorvastatin   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299 
 176   Atx-ms-1467   -   -   -   -   1件:
13 
 177   Aubagio   Teriflunomide   D10172   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   1件:
13 
 178   Aubagio - 14 mg - compressa rivestita con film - uso orale - blister (alu/alu) - 28 compresse   Teriflunomide   D10172   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   1件:
13 
 179   Aubagio®   -   -   -   -   1件:
13 
 180   Autologous adipose derived mesenchymal cells   -   -   -   -   1件:
13 
 181   Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved   -   -   -   -   1件:
13 
 182   Autologous bone marrow-derived mononuclear stem cells   -   -   -   -   1件:
13 
 183   Autologous cd4+t cells stimulated and expanded ex vivo by a mog peptide modified by the introduction of a thioreductase motif into the flanking residues of the t cell epitope   -   -   -   -   1件:
13 
 184   Autologous hematopoietic stem cell   -   -   -   -   1件:
13 
 185   Autologous mesenchymal cell product   -   -   -   -   1件:
13 
 186   Autologous mesenchymal stem cell transplantation   -   -   -   -   1件:
13 
 187   Autologous mesenchymal stem cells   -   -   -   -   5件:
2,
6,
13,
17,
46 
 188   Autologous stem cells   -   -   -   -   2件:
13,
51 
 189   Autologous t-lymphocytes   -   -   -   -   1件:
13 
 190   Autologous vitd3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (toldc-vitd3)   -   -   -   -   1件:
13 
 191   Av605   -   -   -   -   1件:
13 
 192   Avonex   Water   D00001   -   -   2件:
13,
97 
 193   Avonex (interferon beta 1a)   Water, Human interferon beta, Interferon beta-1a, interferon beta   D00001, D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 194   Avonex (interferon beta-1a), biogen idec ltd   Water, Human interferon beta, Interferon beta-1a, interferon beta   D00001, D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 195   Avonex 30 µg/0,5 ml solution for injection   Water   D00001   -   -   1件:
13 
 196   Avonex and topamax   -   -   -   -   1件:
13 
 197   Avonex im 4sir 30mcg/0,5ml 4ag   Water   D00001   -   -   1件:
13 
 198   Avonex/betaseron/copaxone/rebif   -   -   -   -   1件:
13 
 199   Avonex/zocor   -   -   -   -   1件:
13 
 200   Avonex®   -   -   -   -   1件:
13 
 201   Avonex® monotherapy (6.0 miu administered i.m. each week)   -   -   -   -   1件:
13 
 202   Avp-923   -   -   -   -   3件:
2,
6,
13 
 203   Azathioprine   Azathioprine   D00238, D03033   -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 204   Azatioprina   Azathioprine   D00238, D03033   -   -   3件:
13,
96,
97 
 205   Azatioprina hex. 50cpr 50mg bl   Azathioprine   D00238, D03033   -   -   1件:
13 
 206   Azithromycin   Azithromycin   D02134, D06390, D07486   -   -   6件:
13,
84,
85,
96,
228,
299 
 207   Bacille calmette-guerin vaccine   -   -   -   -   1件:
13 
 208   Bacille of calmette-guerin   -   -   -   -   1件:
13 
 209   Baclofen   Baclofen   D00241   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   5件:
2,
10,
13,
18,
149 
 210   Baclofen 20 mg   Baclofen   D00241   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 211   Baclofen ir   Baclofen   D00241   2件: GABBR1, GABBR2   7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway   1件:
13 
 212   Baf312   -   -   -   -   2件:
13,
50 
 213   Baf312 0,25 mg tablet   -   -   -   -   1件:
13 
 214   Baf312 1 mg tablet   -   -   -   -   2件:
13,
50 
 215   Baf312 4 mg tablet   -   -   -   -   1件:
13 
 216   Baf312 hemifumarate   -   -   -   -   2件:
13,
50 
 217   Baf312a   -   -   -   -   1件:
13 
 218   Bafiertam   -   -   -   -   1件:
13 
 219   Balance   Isoxaflutole   -   -   -   8件:
5,
6,
13,
18,
81,
113,
149,
299 
 220   Baminercept   Baminercept   D08866   1件: LTB   3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
13,
46,
53,
97 
 221   Baseline treatment   -   -   -   -   1件:
13 
 222   Bat4406f   -   -   -   -   1件:
13 
 223   Bay 79-4998   -   -   -   -   1件:
13 
 224   Bay86-5046   -   -   -   -   1件:
13 
 225   Bay86-5046_interferon-beta-1b   -   -   -   -   1件:
13 
 226   Bazedoxifene   Bazedoxifene   D03062   -   -   1件:
13 
 227   Bazedoxifene acetate   Acetate, Bazedoxifene   D03062   -   -   1件:
13 
 228   Bbr 2778   -   -   -   -   2件:
11,
13 
 229   Bcd-033 (interferon beta 1a)   Human interferon beta, Interferon beta-1a, interferon beta   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 230   Bcd-054 180 mcg   -   -   -   -   1件:
13 
 231   Bcd-054 240 mcg   -   -   -   -   1件:
13 
 232   Bcd-063   -   -   -   -   1件:
13 
 233   Bcd-132   -   -   -   -   1件:
13 
 234   Bcg20-0134   -   -   -   -   1件:
13 
 235   Beam   Sodium fluoride   D00943   -   -   1件:
13 
 236   Beam regimen   Sodium fluoride   D00943   -   -   1件:
13 
 237   Beetainterferoni -1a   -   -   -   -   1件:
13 
 238   Best available therapy (bat)   -   -   -   -   1件:
13 
 239   Beta interferon   beta interferon   -   -   -   1件:
13 
 240   Beta-1b interferoni   -   -   -   -   1件:
13 
 241   Beta-alanine   L-Alanine, Beta-Alanine   D00012, D07561   -   -   1件:
13 
 242   Beta-alanine supplementation   L-Alanine, Beta-Alanine   D00012, D07561   -   -   1件:
13 
 243   Beta-carotene   Beta carotene   D03101   -   -   1件:
13 
 244   Beta-interferon   beta-interferon   -   -   -   1件:
13 
 245   Betacarotene   Beta carotene   D03101   -   -   1件:
13 
 246   Betaferon   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 247   Betaferon 250 microgram/ml   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 248   Betaferon 250 microgram/ml, powder and solvent for solution for injection   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 249   Betaferon 250µg   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 250   Betaferon 500mcg   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 251   Betaferon 500µg   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 252   Betaferon sc 15f 0,25mg 15sir   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 253   Betaferon*15confez 0,25mg/ml+   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 254   Betaferon, bay 86-5046   -   -   -   -   1件:
13 
 255   Betaferon/betaseron   -   -   -   -   1件:
13 
 256   Betaferon®   -   -   -   -   1件:
13 
 257   Betaferon® (interferon beta-1b)   Human interferon beta, Interferon beta-1b, interferon beta   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 258   Betaseron   Interferon beta-1b   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 259   Betaseron (interferon beta-1b, bay86-5046)   Interferon beta-1b, Human interferon beta, interferon beta   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 260   Betaseron (interferon beta-1b, bay86-5046), bayer healthcare ag   Interferon beta-1b, Human interferon beta, interferon beta   D00746   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 261   Betmiga   Mirabegron   D09535   1件: ADRB3   7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway   1件:
13 
 262   Bevacizumab   Bevacizumab   D06409   1件: VEGFA   21件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway   9件:
13,
34,
85,
86,
87,
89,
227,
280,
331 
 263   Bexarotene   Bexarotene   D03106   3件: RXRA, RXRB, RXRG   15件: Adipocytokine signaling pathway, Bile secretion, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease (NAFLD), Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer   2件:
13,
75 
 264   Bg00002   -   -   -   -   1件:
13 
 265   Bg00002 (natalizumab)   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 266   Bg00002-e (natalizumab high titer)   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 267   Bg00012   bg00012   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   2件:
13,
46 
 268   Bg00012 (dmf)   bg00012   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
13 
 269   Bg00012 (dmf) (tecfidera®.)   bg00012   D03846   1件: KEAP1   4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis   1件:
13 
 270   Bg0002 (natalizumab)   Natalizumab   D06886   1件: ITGA4   14件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection   1件:
13 
 271   Bg9418 (interferon beta 1-a)   Human interferon beta, Interferon beta-1a, interferon beta   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 272   Bg9418 (interferon beta-1a)   Human interferon beta, Interferon beta-1a, interferon beta   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   2件:
13,
97 
 273   Bgg492   -   -   -   -   1件:
13 
 274   Bht-3009   -   -   -   -   1件:
13 
 275   Bht-3009 0.5 mg   -   -   -   -   1件:
13 
 276   Bht-3009 1.5 mg   -   -   -   -   1件:
13 
 277   Bht-3009-01   -   -   -   -   1件:
13 
 278   Biib017   -   -   -   -   1件:
13 
 279   Biib017 (peginterferon beta-1a)   Peginterferon beta-1a   D10483   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   1件:
13 
 280   Biib019   -   -   -   -   1件:
13 
 281   Biib019 (daclizumab)   Daclizumab   D03639   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   1件:
13 
 282   Biib033   -   -   -   -   1件:
13 
 283   Biib033 (anti-lingo)   -   -   -   -   1件:
13 
 284   Biib033 (opicinumab)   Opicinumab   -   -   -   1件:
13 
 285   Biib041   -   -   -   -   1件:
13 
 286   Biib041 (fampridine)   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 287   Biib041 (fampridine-sr)   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 288   Biib041 (pr fampridine)   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
13 
 289   Biib061   -   -   -   -   1件:
13 
 290   Biotin   Biotin   D00029   -   -   3件:
2,
13,
20 
 291   Birt 2584 xx   -   -   -   -   1件:
13 
 292   Bisacodyl   Bisacodyl   D00245   -   -   1件:
13 
 293   Blood sample   -   -   -   -   12件:
8,
13,
46,
49,
51,
53,
61,
66,
97,
274,
288,
299 
 294   Blood samples   -   -   -   -   8件:
13,
41,
46,
51,
61,
97,
227,
271 
 295   Blood sampling   -   -   -   -   4件:
13,
19,
51,
96 
 296   Bmmnc   -   -   -   -   2件:
13,
57 
 297   Bms 188667 (abatacept)   Abatacept, bms 188667   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   1件:
13 
 298   Bone marrow autologous mesenchymal stem cells transplantation   -   -   -   -   1件:
13 
 299   Borage oil   Borage oil   -   -   -   1件:
13 
 300   Borage oil 20% gla   Borage oil   -   -   -   1件:
13 
 301   Bosentan   Bosentan   D01227, D07538   2件: EDNRA, EDNRB   9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   9件:
13,
41,
47,
51,
84,
85,
86,
88,
210 
 302   Boswelan   -   -   -   -   1件:
13 
 303   Boswellia serrata   Indian frankincense   -   -   -   1件:
13 
 304   Boswellia serrata extract   Indian frankincense   -   -   -   1件:
13 
 305   Boswellia serrata extract ps0201bo capsules   Indian frankincense   -   -   -   1件:
13 
 306   Boswellic acids (boswelan)   -   -   -   -   1件:
13 
 307   Botox   Botulinum toxin type A   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   4件:
6,
13,
149,
226 
 308   Botox®   -   -   -   -   1件:
13 
 309   Botulinum toxin a   Botulinum toxin type A   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   4件:
13,
51,
149,
226 
 310   Botulinum toxin a - haemagglutinin complex   Botulinum toxin type A   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   1件:
13 
 311   Botulinum toxin type a   Botulinum toxin type A   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   10件:
2,
5,
6,
7,
13,
15,
17,
70,
113,
149 
 312   Bx-1   -   -   -   -   1件:
13 
 313   C1-esterase inhibitor (cinryze)   -   -   -   -   1件:
13 
 314   C105   -   -   -   -   1件:
13 
 315   Calcio   Calcium   -   -   -   1件:
13 
 316   Calcio folinato dc.it   Calcium   -   -   -   1件:
13 
 317   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 318   Calcium carbonate   Calcium, Carbonate ion   -   -   -   7件:
13,
19,
46,
75,
96,
235,
299 
 319   Calcium levofolinate   Calcium   -   -   -   1件:
13 
 320   Cannabidiol   Cannabidiol   D10915   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   13件:
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 321   Cannabidiol / dronabinol capsule 5 mg+2,5 mg   Cannabidiol, Dronabinol   D00306, D10915   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
13 
 322   Cannabidiol capsule 5 mg   Cannabidiol   D10915   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
13 
 323   Cannabis   Medical Cannabis   -   -   -   6件:
2,
6,
13,
90,
96,
97 
 324   Cannabis based medicine extract (sativex)   Medical Cannabis   -   -   -   1件:
13 
 325   Cannabis, medical   Medical Cannabis   -   -   -   5件:
2,
6,
13,
96,
97 
 326   Cannador   -   -   -   -   1件:
13 
 327   Caprylic triglyceride   Tricaprylin   -   -   -   1件:
13 
 328   Capsules with 160 mg teavigo (at least 94% egcg)   Epigallocatechin gallate   -   -   -   1件:
13 
 329   Carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   8件:
2,
4,
6,
13,
17,
90,
164,
201 
 330   Carbonate   Carbonate ion   -   -   -   10件:
2,
13,
17,
19,
46,
75,
96,
127,
235,
299 
 331   Carmustine   Carmustine   D00254   -   -   5件:
11,
13,
14,
28,
60 
 332   Carmustine, etoposide, cytarabine, and melphalan (beam)   Sodium fluoride, Carmustine, Cytarabine, Etoposide, Melphalan   D00125, D00168, D00254, D00369, D00943, D03046, D03637, D04107   2件: TOP2A, TOP2B   1件: Platinum drug resistance   1件:
13 
 333   Carnitine   Levocarnitine   D02030, D02176, D04713   -   -   8件:
5,
13,
58,
96,
97,
265,
298,
316 
 334   Carnosine   Carnosine   -   -   -   2件:
6,
13 
 335   Carnosine, capsulle, 2 g/day, 8 weeks   Carnosine   -   -   -   1件:
13 
 336   Cci-779   -   -   -   -   2件:
13,
46 
 337   Cdp323   CDP323   -   -   -   1件:
13 
 338   Cellular therapy with ebv specific autologous ctl infusion   -   -   -   -   1件:
13 
 339   Ceralifimod   -   -   -   -   1件:
13 
 340   Ceralifmod   -   -   -   -   1件:
13 
 341   Cesamet™ (nabilone)   Nabilone   D05099   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
13 
 342   Ceterizine   -   -   -   -   1件:
13 
 343   Cetirizina   Cetirizine   D00664, D07662   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
13 
 344   Cetirizina mylan generics   Cetirizine   D00664, D07662   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
13 
 345   Cetirizine   Cetirizine   D00664, D07662   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   2件:
13,
35 
 346   Cetirizine hydrochloride   Cetirizine   D00664, D07662   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
13 
 347   Cgp 77116   -   -   -   -   1件:
13 
 348   Charcoal   Activated charcoal   D03251   -   -   1件:
13 
 349   Chloride   Chloride ion   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299 
 350   Cholecalciferol   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   9件:
13,
19,
34,
46,
49,
96,
97,
298,
299 
 351   Cholecalciferol, vitamin d3   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
13 
 352   Cholestyramine   Cholestyramine   -   -   -   2件:
13,
79 
 353   Chr-1103 / gbr500   -   -   -   -   1件:
13 
 354   Cianocobalamina   Cyanocobalamin   D00166, D03615, D03616, D03617   -   -   1件:
13 
 355   Cianocobalamina fu dc.it   Cyanocobalamin   D00166, D03615, D03616, D03617   -   -   1件:
13 
 356   Ciclofosfamide   Cyclophosphamide   D00287, D07760   -   -   1件:
13 
 357   Circadin   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   1件:
13 
 358   Circadin ( inn= melatonin)   Melatonin   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   1件:
13 
 359   Cisapride   Cisapride   D00274, D02092   3件: HTR2A, HTR3A, HTR4   7件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway   1件:
13 
 360   Cladribine   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   2件:
13,
94 
 361   Cladribine 3.5 mg/kg   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 362   Cladribine 5.25 mg/kg   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 363   Cladribine tablets   Cladribine   D01370   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   1件:
13 
 364   Clemastine   Clemastine   D00666, D03535   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
13 
 365   Clostridium botulinum   Clostridium botulinum   -   -   -   1件:
13 
 366   Clostridium botulinum toxin type a   Botulinum toxin type A, Clostridium botulinum   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   1件:
13 
 367   Cnm-au8   -   -   -   -   2件:
2,
13 
 368   Cnp-ms-0601   -   -   -   -   1件:
13 
 369   Cnto 1275   cnto 1275   D09214   3件: IL12A, IL12B, IL23A   25件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus   2件:
13,
96 
 370   Co-14   -   -   -   -   1件:
13 
 371   Coconut   Coconut   -   -   -   1件:
13 
 372   Coconut oil   Coconut, Coconut oil   D05326   -   -   1件:
13 
 373   Coconut oil and epigallocatechin gallate   Coconut, Coconut oil, Epigallocatechin, Epigallocatechin gallate   D05326   -   -   1件:
13 
 374   Coenzyme q   -   -   -   -   1件:
13 
 375   Colecalciferol   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   4件:
13,
46,
96,
228 
 376   Colecalciferol concentrate (oily form)   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
13 
 377   Control   Chloroxylenol   D03473   -   -   4件:
6,
13,
46,
168 
 378   Cop-1   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 379   Cop-1/copolymer-1   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 380   Copaxone   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 381   Copaxone 20 mg/ml   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 382   Copaxone 20 mg/ml solution for injection, pre-filled syringe   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 383   Copaxone 40 mg/ml solution for injection, pre-filled syringe   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 384   Copaxone subcutaneous injection syringe   -   -   -   -   1件:
13 
 385   Copaxone-teva   -   -   -   -   1件:
13 
 386   Copaxone®   -   -   -   -   1件:
13 
 387   Copolymer 1   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease (IBD), Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis   1件:
13 
 388   Copolymer-1   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection,